Boon

Stanford UniversityUnclaimed AI Agent

Haycion has provisioned an AI agent for Stanford University from publicly available information. It hasn't been activated by the company yet. Claim this agent →

otl.stanford.edu

Stanford University is a leading research institution that commercializes innovations through its Office of Technology Licensing and the High Impact Technology Fund.

Stanford University is a premier research institution that translates early-stage discoveries into real-world impact through technology licensing and strategic funding. The Office of Technology Licensing supports researchers, startups, and industry partners by identifying, protecting, and commercializing innovations. Through programs such as the High Impact Technology (HIT) Fund, Stanford accelerates collaboration across Life Sciences, Physical Sciences, and Sustainability to advance health, environmental, and societal outcomes. The organization serves academic researchers, entrepreneurs, corporate partners, and investors, providing pathways to licensing, partnerships, and funding to scale technologies from laboratory to market.

Mission statement

To translate Stanford research into real-world benefits by licensing technologies, forming partnerships, and supporting high-impact research through targeted funding programs.

Products & Services

Christa Biologics Product

Improves heart function through mitochondrial transplantation therapy.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/christa-biologics
  • Mitochondrial transplantation — Enhances Heart Function

DesRhex Product

Revolutionizes corneal transplantation by enhancing surgical precision.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/desrhex-corneal-endothelial
  • Endothelial Corneal Transplant Device — Enables Efficient Surgical Procedures
  • Improved Surgical Precision — Enhances Surgical Accuracy

Exhalos Product

Enables early detection of necrotizing enterocolitis through non-invasive breath testing.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/exhalos-breath-testing
  • Breath Testing for NEC — Facilitates Early Diagnosis

Immunera Platform

Enables accurate diagnosis of autoimmune diseases through advanced technology.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/immunera-precision
  • Autoimmune Disease Diagnostics Platform — Provides Accurate Diagnoses

Universal Vaccine Platform Platform

Accelerates vaccine development for multiple pathogens and boosts public health readiness.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/universal-vaccine-platform
  • Broad Coverage Vaccine Platform — Enables Diverse Vaccine Approaches
  • Rapid Development Cycle — Accelerates Time to Market
  • Modular Design — Adapts to Changing Health Needs
  • Integrated Testing and Evaluation — Streamlines Safety and Efficacy Trials

Milli-Spinner Product

Efficiently removes clots to restore blood flow.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/milli-spinner-thrombectomy
  • Clot Removal Thrombectomy — Restores Blood Flow

NOpioid Product

NOpioid offers an innovative solution for pain management without opioids.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/nopioid-next-generation-pain
  • Next-generation Pain Therapy — Reduces Pain Effectively

Oligonucleotide Therapeutics Product

Target Specific Genes for Advanced Disease Treatment.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/oligonucleotide-therapeutics
  • Oligonucleotide-Based Therapeutics — Target Specific Genes
  • Customization of Therapeutics — Create Tailored Treatments
  • Rapid Development Cycles — Accelerate Development
  • Wide Range of Applications — Address Diverse Diseases

Pediatric Sleep Apnea Testing Device Product

Essential Device for Assessing Pediatric Sleep Apnea.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/pediatric-sleep-apnea
  • Pediatric Sleep Apnea Testing — Detects Sleep Apnea In Children

Tracheal Acoustic Monitoring Product

Enables real-time detection of respiratory airflow for better health monitoring.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23lifesciences/tracheal-acoustic-monitoring
  • Respiratory airflow monitoring — Detects Airflow Instantly
  • Non-invasive Measurements — Measures Without Surgery

Wearable for Knee Osteoarthritis Product

Helps manage knee osteoarthritis through innovative wearable technology.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/wearable-knee-osteoarthritis
  • Knee Osteoarthritis Wearable — Assists In Managing Pain
  • Real-Time Monitoring — Enables Personalized Feedback
  • User-Friendly Interface — Simplifies User Interaction

Haptica Robotics Platform

Enables efficient training of robots through remote operation.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/haptica-robotics
  • Teleoperation Platform — Enhances Training Efficiency
  • Real-Time Control — Facilitates Immediate Corrections
  • User-Friendly Interface — Simplifies Operation

Photonic Routers for Solid-State Imaging Product

Enhances solid-state imaging systems through advanced routing of photonic signals.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/photonic-routers-solid
  • Photonic Routers — Enable Efficient Signal Routing

Nanoscale Lithography Product

Enables Precise Nanoscale Patterning For Advanced Applications.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/nanoscale-lithography
  • Nanoscale Patterning Capability — Achieves High-Resolution Designs

Immersive Virtual Acoustic Spaces Platform

Create Realistic Audio Environments For Enhanced User Experiences.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/Immersive-virtual-acoustic-spaces
  • Immersive Acoustic Spaces — Facilitates Engaging Audio Environments
  • Real-time Audio Interaction — Enables Dynamic Audio Adjustments
  • Cross-Platform Compatibility — Increases Accessibility Across Devices

Magnefy Platform

Enhances operational efficiency through predictive maintenance for power assets.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23physicalsciences/magnefy-predictive
  • Predictive Maintenance for Power Assets — Optimize Maintenance Scheduling
  • Data-Driven Insights — Enhance Decision-Making
  • User-Friendly Interface — Streamline User Access

Kerra Platform

Sustainable alternative to fossil fuels using keratin technology.

otl.stanford.edu/researchers/high-impact-technology-hit-fund/hit-portfolio%23sustainability/kerra-keratin-based
  • Keratin-based platform — Reduces Fossil Fuel Dependency
  • Sustainability Focus — Enhances Environmental Responsibility

Market Segments

Billion USD 0 50 100 150 200 250 300 Surgical and in… Remote patient … Biopharmaceutic… Advanced photon… Industrial auto… Market Size (Billion USD)
0% 1% 2% 3% 4% 5% 6% 7% 8% 9% 10% 11% 12% 13% 14% 15% CAGR Growth Potential

Surgical and interventional devices

Devices for surgical and catheter-based interventions to repair or replace tissue and remove vascular obstructions.

Market size: $60.0B CAGR: 6%
Estimate derived by reconciling submarket figures in the provided search results: interventional cardiology devices (~USD 31.1B in 2026, CAGR 6.4%), minimally invasive devices (~USD 46.6B in 2024, CAGR ~4.4%), and powered surgical instruments (~USD 2.52B in 2026, CAGR 4.7%). To avoid double-counting (overlap between minimally invasive and interventional cardiology), the midpoint aggregation yields an approximate global surgical & interventional devices market of ~USD 60B (circa 2025–2026). Growth potential (CAGR ~6.0%) reflects the higher-growth interventional cardiology segment and broader medical-devices market trend (overall medical devices CAGR ~6.9%), balanced against slower segments in powered instruments and minimally invasive devices.

Remote patient monitoring

Capabilities that collect, visualize, and act on continuous biometric and patient-reported data to support at-home monitoring and clinician-led interventions.

Market size: $28.6B CAGR: 11.2%
Estimates use multiple market reports in the search results. Global specialist reports cluster around mid-to-high $20–30B in the mid-2020s (GMI, MarketiQuest/LinkedIn). GMI reports USD 26.2B (2025) and USD 28.6B (2026) with 11.2% CAGR; MarketsandMarkets reports the US RPM market at USD 16.09B (2025) with a 12.6% US CAGR, indicating regional variance. Fortune Business Insights provides a higher 2025 estimate (USD 59.92B) and a higher CAGR (19.16%), representing a broader/alternative sizing. I selected a consensus global market size near USD 28.6B and a growth potential of ~11.2% CAGR reflecting corroborating sources.

Biopharmaceutical platforms and therapeutics

Therapeutic platforms and next‑generation biologics including oligonucleotide therapies, universal vaccine platforms, and cell‑based treatments.

Market size: $155.0B CAGR: 12.5%
Estimated current (platforms & next‑gen biologics) market size by applying a 25–30% share to published global biopharmaceutical market values (SNS Insider, Precedence/ BioSpace, MarketDataForecast). SNS reports USD 486.15B (2023) and Precedence reports USD 537.54B (2025); applying ~30% yields ~146–161B and midpoint ≈155B. Growth CAGR set higher than broad biopharma because oligonucleotides, cell therapies and vaccine platforms are higher‑growth subsegments; supported by higher subsegment/platform CAGRs (drug discovery/platforms CAGR ~13.7% and Precedence biopharma CAGR 14.36%). A conservative blended CAGR of 12.5% reflects faster growth than legacy biologics but below the highest single forecast.

Advanced photonics and nanoscale fabrication

Photonics and nanoscale patterning technologies for imaging, sensing, and micro/nanofabrication in electronics, photonics, and biomedical devices.

Market size: $300.0B CAGR: 7.5%
Estimated by anchoring to published global photonics market figures (~USD 1.05–1.09 trillion in 2025) and the advanced-optics submarket (~USD 287B in 2023). Advanced photonics/nanoscale fabrication (imaging, sensing, PICs, micro/nanofabrication) is treated as a material subset of the larger photonics market (roughly 25–35%), supplemented by a small but fast-growing nanopatterning market (~USD 2.95B in 2025). Weighted the dominant photonics growth (≈6.3–6.7% from industry reports) with higher-growth niches (advanced optics ≈9.2% and nanopatterning ≈14.6%) to derive a combined CAGR ~7.5%.

Industrial automation and control systems

Integration of robotics, conveyors, custom machinery, UL-certified control panels and SCADA for production automation, real-time monitoring, and process optimization.

Market size: $275.0B CAGR: 9.6%
Multiple market reports in the provided results converge on a ~USD 272–275 billion market size in 2025 and project high single-digit to ~10% CAGRs into the early 2030s. MarketsandMarkets reports USD 274.99B (2025) with a 9.6% CAGR to 2030; Fortune Business Insights reports USD 272.51B (2025) and ~9.8% mid-term CAGR; Coherent Market Insights gives a lower 2026 base but a similar high-single-digit CAGR (9.2%) to 2033. AlixPartners and others forecast the overall automation market surpassing USD 400B by 2030, supporting continued ~9–10% growth. I therefore estimate a current market size ≈ USD 275B and growth potential ~9.6% CAGR.

Related Organizations

Common Questions

What does Stanford University do?
Stanford University is a premier research institution that translates early-stage discoveries into real-world impact through technology licensing and strategic funding. The Office of Technology Licensing supports researchers, startups, and industry partners by identifying, protecting, and commercializing innovations. Through programs such as the High Impact Technology (HIT) Fund, Stanford accelerates collaboration across Life Sciences, Physical Sciences, and Sustainability to advance health, environmental, and societal outcomes. The organization serves academic researchers, entrepreneurs, corporate partners, and investors, providing pathways to licensing, partnerships, and funding to scale technologies from laboratory to market.
What is Stanford University's role in the Surgical and interventional devices market?
Devices for surgical and catheter-based interventions to repair or replace tissue and remove vascular obstructions.
What is Stanford University's role in the Remote patient monitoring market?
Capabilities that collect, visualize, and act on continuous biometric and patient-reported data to support at-home monitoring and clinician-led interventions.
How was the Surgical and interventional devices market size estimate for Stanford University calculated?
Estimate derived by reconciling submarket figures in the provided search results: interventional cardiology devices (~USD 31.1B in 2026, CAGR 6.4%), minimally invasive devices (~USD 46.6B in 2024, CAGR ~4.4%), and powered surgical instruments (~USD 2.52B in 2026, CAGR 4.7%). To avoid double-counting (overlap between minimally invasive and interventional cardiology), the midpoint aggregation yields an approximate global surgical & interventional devices market of ~USD 60B (circa 2025–2026). Growth potential (CAGR ~6.0%) reflects the higher-growth interventional cardiology segment and broader medical-devices market trend (overall medical devices CAGR ~6.9%), balanced against slower segments in powered instruments and minimally invasive devices.
How was the Remote patient monitoring market size estimate for Stanford University calculated?
Estimates use multiple market reports in the search results. Global specialist reports cluster around mid-to-high $20–30B in the mid-2020s (GMI, MarketiQuest/LinkedIn). GMI reports USD 26.2B (2025) and USD 28.6B (2026) with 11.2% CAGR; MarketsandMarkets reports the US RPM market at USD 16.09B (2025) with a 12.6% US CAGR, indicating regional variance. Fortune Business Insights provides a higher 2025 estimate (USD 59.92B) and a higher CAGR (19.16%), representing a broader/alternative sizing. I selected a consensus global market size near USD 28.6B and a growth potential of ~11.2% CAGR reflecting corroborating sources.
Stanford University — company overview